PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 63 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $21,000 | -8.7% | 35,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $23,000 | +283.3% | 35,000 | +73.3% | 0.00% | +100.0% |
| Q4 2016 | $6,000 | -14.3% | 20,193 | +22.4% | 0.00% | 0.0% |
| Q3 2016 | $7,000 | +16.7% | 16,500 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $6,000 | -14.3% | 16,500 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $7,000 | -63.2% | 16,500 | 0.0% | 0.00% | -66.7% |
| Q4 2015 | $19,000 | +35.7% | 16,500 | +17.9% | 0.00% | +50.0% |
| Q3 2015 | $14,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Freedom Investment Management, Inc. | 143,595 | $451,000 | 0.02% |
| BAXTER BROS INC | 21,501 | $68,000 | 0.02% |